Profiel
Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.
Eerdere bekende functies van Richard Schwartz
| Bedrijven | Functie | Einde |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 01-10-2019 |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | 01-05-2008 |
| Vaccine Research Center | Corporate Officer/Principal | - |
| VAXART, INC. | Chief Tech/Sci/R&D Officer | - |
| SYNLOGIC, INC. | Corporate Officer/Principal | - |
Opleiding van Richard Schwartz
| University of Michigan | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| VAXART, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
| Vaccine Research Center |
